Literature DB >> 30788613

The Comprehensive Management of Cerebellar Ataxia in Adults.

Christopher D Stephen1,2,3, Kate T Brizzi4,5, Marc A Bouffard4,6, Pablo Gomery7, Stacey L Sullivan8, Julie Mello9, Julie MacLean10, Jeremy D Schmahmann4,11,12.   

Abstract

PURPOSE OF REVIEW: In this review, we present the multidisciplinary approach to the management of the many neurological, medical, social, and emotional issues facing patients with cerebellar ataxia. RECENT
FINDINGS: Our holistic approach to treatment, developed over the past 25 years in the Massachusetts General Hospital Ataxia Unit, is centered on the compassionate care of the patient and their family, empowering them through engagement, and including the families as partners in the healing process. We present the management of ataxia in adults, beginning with establishing an accurate diagnosis, followed by treatment of the multiple symptoms seen in cerebellar disorders, with a view to maximizing quality of life and effectively living with the consequences of ataxia. We discuss the importance of a multidisciplinary approach to the management of ataxia, including medical and non-medical management and the evidence base that supports these interventions. We address the pharmacological treatment of ataxia, tremor, and other associated movement disorders; ophthalmological symptoms; bowel, bladder, and sexual symptoms; orthostatic hypotension; psychiatric and cognitive symptoms; neuromodulation, including deep brain stimulation; rehabilitation including physical therapy, occupational therapy and speech and language pathology and, as necessary, involving urology, psychiatry, and pain medicine. We discuss the role of palliative care in late-stage disease. The management of adults with ataxia is complex and a team-based approach is essential.

Entities:  

Keywords:  Cerebellar ataxia; Palliative care; Pharmacological and non-pharmacological management; Treatment

Year:  2019        PMID: 30788613     DOI: 10.1007/s11940-019-0549-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  7 in total

1.  Pediatric post-operative cerebellar mutism syndrome, cerebellar cognitive affective syndrome, and posterior fossa syndrome: historical review and proposed resolution to guide future study.

Authors:  Jeremy D Schmahmann
Journal:  Childs Nerv Syst       Date:  2019-06-25       Impact factor: 1.475

Review 2.  Update on the Treatment of Ataxia: Medication and Emerging Therapies.

Authors:  Susan L Perlman
Journal:  Neurotherapeutics       Date:  2020-10-06       Impact factor: 7.620

3.  Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study.

Authors:  Gail L Widener; Nicole Conley; Sarah Whiteford; Jason Gee; Anthony Harrell; Cynthia Gibson-Horn; Valerie Block; Diane D Allen
Journal:  Physiother Res Int       Date:  2019-11-20

Review 4.  Palliative Care in Movement Disorders: an Evolving Field.

Authors:  Zachary A Macchi; Christopher G Tarolli; Benzi M Kluger
Journal:  Curr Neurol Neurosci Rep       Date:  2021-01-28       Impact factor: 5.081

5.  Clinical therapeutic effects of gastrodin in combination with betahistine on vertigo: A protocol for systematic review and meta-analysis.

Authors:  Yu-Lin Qiao; Wen-Qiang Xiang; Fang Liu; Sheng Jin
Journal:  Medicine (Baltimore)       Date:  2021-03-12       Impact factor: 1.817

Review 6.  In Search of Molecular Markers for Cerebellar Neurons.

Authors:  Wing Yip Tam; Xia Wang; Andy S K Cheng; Kwok-Kuen Cheung
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

7.  Characterization of Mesenchymal Stem Cells Derived from Patients with Cerebellar Ataxia: Downregulation of the Anti-Inflammatory Secretome Profile.

Authors:  Jong-Heon Kim; Jin Han; Donggun Seo; Jong Hyuk Yoon; Dongyeong Yoon; Jungwan Hong; Sang Ryong Kim; Min Sung Kim; Tae Yong Lee; Kyung-Suk Kim; Pan-Woo Ko; Ho-Won Lee; Kyoungho Suk
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.